EMEA (Europe, Middle East and Africa) Anthrax Vaccines Market Report 2017

December 2017 | 129 pages | ID: EB3D59C3D74EN
QYResearch

Abstracts

In this report, the EMEA Anthrax Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Anthrax Vaccines for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anthrax Vaccines market competition by top manufacturers/players, with Anthrax Vaccines sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Agrovet
• Bayer Sanidad Animal
• Biogénesis-Bago S.A.
• Botswana Vaccine Institute
• CAVAC
• Central Veterinary Control and Research Institute
• Centro Diagnóstico Veterinario
• Ceva Sante Animale
• Colorado Serum Company
• Empresa Colombiana de Productos Veterinarios S.A. (Vecol)
• Indian Immunologicals Limited
• Institute for Biological Products
• Institute of Animal Health and Veterinary Biologicals
• Institute of Veterinary Preventive Medicine
• Instituto Rosenbusch S.A.
• Institutul Pasteur
• Intervac (PVT) Ltd.
• Jordan Bio-Industries Center (JOVAC)
• KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute)
• Laboratorio Prondil S.A.
• Laboratorios Laverlam S.A.
• Merial Argentina

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Cell Free PA Vaccines: Anthrax Vaccine Adsorbed (AVA), Anthrax Vaccine Precipitated (AVP)
• Live Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Human
• Animals

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Anthrax Vaccines Market Report 2017

1 ANTHRAX VACCINES OVERVIEW

1.1 Product Overview and Scope of Anthrax Vaccines
1.2 Classification of Anthrax Vaccines
  1.2.1 EMEA Anthrax Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Anthrax Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Cell Free PA Vaccines: Anthrax Vaccine Adsorbed (AVA), Anthrax Vaccine Precipitated (AVP)
  1.2.4 Live Vaccines
1.3 EMEA Anthrax Vaccines Market by Application/End Users
  1.3.1 EMEA Anthrax Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Human
  1.3.3 Animals
1.4 EMEA Anthrax Vaccines Market by Region
  1.4.1 EMEA Anthrax Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Anthrax Vaccines (2012-2022)
  1.5.1 EMEA Anthrax Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Anthrax Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA ANTHRAX VACCINES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Anthrax Vaccines Market Competition by Players/Manufacturers
  2.1.1 EMEA Anthrax Vaccines Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Anthrax Vaccines Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Anthrax Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Anthrax Vaccines (Volume and Value) by Type/Product Category
  2.2.1 EMEA Anthrax Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Anthrax Vaccines Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Anthrax Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Anthrax Vaccines (Volume) by Application
2.4 EMEA Anthrax Vaccines (Volume and Value) by Region
  2.4.1 EMEA Anthrax Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Anthrax Vaccines Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Anthrax Vaccines Sales Price by Region (2012-2017)

3 EUROPE ANTHRAX VACCINES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Anthrax Vaccines Sales and Value (2012-2017)
  3.1.1 Europe Anthrax Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Anthrax Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Anthrax Vaccines Sales and Market Share by Type
3.3 Europe Anthrax Vaccines Sales and Market Share by Application
3.4 Europe Anthrax Vaccines Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Anthrax Vaccines Sales Volume by Countries (2012-2017)
  3.4.2 Europe Anthrax Vaccines Revenue by Countries (2012-2017)
  3.4.3 Germany Anthrax Vaccines Sales and Growth Rate (2012-2017)
  3.4.4 France Anthrax Vaccines Sales and Growth Rate (2012-2017)
  3.4.5 UK Anthrax Vaccines Sales and Growth Rate (2012-2017)
  3.4.6 Russia Anthrax Vaccines Sales and Growth Rate (2012-2017)
  3.4.7 Italy Anthrax Vaccines Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Anthrax Vaccines Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTHRAX VACCINES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Anthrax Vaccines Sales and Value (2012-2017)
  4.1.1 Middle East Anthrax Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Anthrax Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Anthrax Vaccines Sales and Market Share by Type
4.3 Middle East Anthrax Vaccines Sales and Market Share by Application
4.4 Middle East Anthrax Vaccines Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Anthrax Vaccines Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Anthrax Vaccines Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Anthrax Vaccines Sales and Growth Rate (2012-2017)
  4.4.4 Israel Anthrax Vaccines Sales and Growth Rate (2012-2017)
  4.4.5 UAE Anthrax Vaccines Sales and Growth Rate (2012-2017)
  4.4.6 Iran Anthrax Vaccines Sales and Growth Rate (2012-2017)

5 AFRICA ANTHRAX VACCINES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Anthrax Vaccines Sales and Value (2012-2017)
  5.1.1 Africa Anthrax Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Anthrax Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Anthrax Vaccines Sales and Market Share by Type
5.3 Africa Anthrax Vaccines Sales and Market Share by Application
5.4 Africa Anthrax Vaccines Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Anthrax Vaccines Sales Volume by Countries (2012-2017)
  5.4.2 Africa Anthrax Vaccines Revenue by Countries (2012-2017)
  5.4.3 South Africa Anthrax Vaccines Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Anthrax Vaccines Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Anthrax Vaccines Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Anthrax Vaccines Sales and Growth Rate (2012-2017)

6 EMEA ANTHRAX VACCINES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Agrovet
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anthrax Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Agrovet Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer Sanidad Animal
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Anthrax Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Biogénesis-Bago S.A.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Anthrax Vaccines Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Biogénesis-Bago S.A. Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Botswana Vaccine Institute
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Anthrax Vaccines Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CAVAC
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Anthrax Vaccines Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Central Veterinary Control and Research Institute
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Anthrax Vaccines Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Central Veterinary Control and Research Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Centro Diagnóstico Veterinario
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Anthrax Vaccines Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Centro Diagnóstico Veterinario Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Ceva Sante Animale
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Anthrax Vaccines Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Ceva Sante Animale Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Colorado Serum Company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Anthrax Vaccines Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Colorado Serum Company Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Empresa Colombiana de Productos Veterinarios S.A. (Vecol)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Anthrax Vaccines Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Indian Immunologicals Limited
6.12 Institute for Biological Products
6.13 Institute of Animal Health and Veterinary Biologicals
6.14 Institute of Veterinary Preventive Medicine
6.15 Instituto Rosenbusch S.A.
6.16 Institutul Pasteur
6.17 Intervac (PVT) Ltd.
6.18 Jordan Bio-Industries Center (JOVAC)
6.19 KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute)
6.20 Laboratorio Prondil S.A.
6.21 Laboratorios Laverlam S.A.
6.22 Merial Argentina

7 ANTHRAX VACCINES MANUFACTURING COST ANALYSIS

7.1 Anthrax Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anthrax Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anthrax Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anthrax Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTHRAX VACCINES MARKET FORECAST (2017-2022)

11.1 EMEA Anthrax Vaccines Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Anthrax Vaccines Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Anthrax Vaccines Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Anthrax Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Anthrax Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Anthrax Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Anthrax Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Anthrax Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Anthrax Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Anthrax Vaccines Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Anthrax Vaccines
Figure EMEA Anthrax Vaccines Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Anthrax Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Cell Free PA Vaccines: Anthrax Vaccine Adsorbed (AVA), Anthrax Vaccine Precipitated (AVP) Product Picture
Figure Live Vaccines Product Picture
Figure EMEA Anthrax Vaccines Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Anthrax Vaccines by Application in 2016
Figure Human Examples
Table Key Downstream Customer in Human
Figure Animals Examples
Table Key Downstream Customer in Animals
Figure EMEA Anthrax Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Anthrax Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Anthrax Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Anthrax Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anthrax Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Anthrax Vaccines Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Anthrax Vaccines Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Anthrax Vaccines Sales Share by Players (2012-2017)
Figure 2016 Anthrax Vaccines Sales Share by Players
Figure 2017 Anthrax Vaccines Sales Share by Players
Figure EMEA Anthrax Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Anthrax Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Anthrax Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Anthrax Vaccines Revenue Share by Players
Table 2017 EMEA Anthrax Vaccines Revenue Share by Players
Table EMEA Anthrax Vaccines Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Anthrax Vaccines Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Anthrax Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Anthrax Vaccines by Type (2012-2017)
Figure EMEA Anthrax Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Anthrax Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Anthrax Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anthrax Vaccines by Type in 2016
Table EMEA Anthrax Vaccines Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Anthrax Vaccines Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Anthrax Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Anthrax Vaccines by Application (2012-2017)
Figure EMEA Anthrax Vaccines Sales Market Share by Application in 2016
Table EMEA Anthrax Vaccines Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Anthrax Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Anthrax Vaccines by Region (2012-2017)
Figure EMEA Anthrax Vaccines Sales Market Share in 2016
Table EMEA Anthrax Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Anthrax Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Anthrax Vaccines by Region (2012-2017)
Figure EMEA Anthrax Vaccines Revenue Market Share Regions in 2016
Table EMEA Anthrax Vaccines Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Anthrax Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Anthrax Vaccines Sales (K Pcs) by Type (2012-2017)
Table Europe Anthrax Vaccines Market Share by Type (2012-2017)
Figure Europe Anthrax Vaccines Market Share by Type in 2016
Table Europe Anthrax Vaccines Sales (K Pcs) by Application (2012-2017)
Table Europe Anthrax Vaccines Market Share by Application (2012-2017)
Figure Europe Anthrax Vaccines Market Share by Application in 2016
Table Europe Anthrax Vaccines Sales (K Pcs) by Countries (2012-2017)
Table Europe Anthrax Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Anthrax Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Anthrax Vaccines Sales Market Share by Countries in 2016
Table Europe Anthrax Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Anthrax Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Anthrax Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Anthrax Vaccines Revenue Market Share by Countries in 2016
Figure Germany Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Anthrax Vaccines Sales (K Pcs) by Type (2012-2017)
Table Middle East Anthrax Vaccines Market Share by Type (2012-2017)
Figure Middle East Anthrax Vaccines Market Share by Type (2012-2017)
Table Middle East Anthrax Vaccines Sales (K Pcs) by Applications (2012-2017)
Table Middle East Anthrax Vaccines Market Share by Applications (2012-2017)
Figure Middle East Anthrax Vaccines Sales Market Share by Application in 2016
Table Middle East Anthrax Vaccines Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Anthrax Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Anthrax Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Anthrax Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Anthrax Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Anthrax Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Anthrax Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Anthrax Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Anthrax Vaccines Sales (K Pcs) by Type (2012-2017)
Table Africa Anthrax Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Anthrax Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Anthrax Vaccines Sales Market Share by Type in 2016
Table Africa Anthrax Vaccines Sales (K Pcs) by Application (2012-2017)
Table Africa Anthrax Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Anthrax Vaccines Sales Market Share by Application (2012-2017)
Table Africa Anthrax Vaccines Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Anthrax Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Anthrax Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Anthrax Vaccines Sales Market Share by Countries in 2016
Table Africa Anthrax Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Anthrax Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Anthrax Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Anthrax Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Table Agrovet Anthrax Vaccines Basic Information List
Table Agrovet Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Agrovet Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Agrovet Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Agrovet Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Bayer Sanidad Animal Anthrax Vaccines Basic Information List
Table Bayer Sanidad Animal Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Sanidad Animal Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer Sanidad Animal Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Bayer Sanidad Animal Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Biogénesis-Bago S.A. Anthrax Vaccines Basic Information List
Table Biogénesis-Bago S.A. Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogénesis-Bago S.A. Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biogénesis-Bago S.A. Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Biogénesis-Bago S.A. Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Botswana Vaccine Institute Anthrax Vaccines Basic Information List
Table Botswana Vaccine Institute Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Botswana Vaccine Institute Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Botswana Vaccine Institute Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Botswana Vaccine Institute Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table CAVAC Anthrax Vaccines Basic Information List
Table CAVAC Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CAVAC Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure CAVAC Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure CAVAC Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Central Veterinary Control and Research Institute Anthrax Vaccines Basic Information List
Table Central Veterinary Control and Research Institute Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Central Veterinary Control and Research Institute Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Central Veterinary Control and Research Institute Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Central Veterinary Control and Research Institute Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Centro Diagnóstico Veterinario Anthrax Vaccines Basic Information List
Table Centro Diagnóstico Veterinario Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Centro Diagnóstico Veterinario Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Centro Diagnóstico Veterinario Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Centro Diagnóstico Veterinario Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Ceva Sante Animale Anthrax Vaccines Basic Information List
Table Ceva Sante Animale Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ceva Sante Animale Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Ceva Sante Animale Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Ceva Sante Animale Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Colorado Serum Company Anthrax Vaccines Basic Information List
Table Colorado Serum Company Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Colorado Serum Company Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Colorado Serum Company Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Colorado Serum Company Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Basic Information List
Table Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Sales (K Pcs) and Growth Rate (2012-2017)
Figure Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Sales Market Share in EMEA (2012-2017)
Figure Empresa Colombiana de Productos Veterinarios S.A. (Vecol) Anthrax Vaccines Revenue Market Share in EMEA (2012-2017)
Table Indian Immunologicals Limited Anthrax Vaccines Basic Information List
Table Institute for Biological Products Anthrax Vaccines Basic Information List
Table Institute of Animal Health and Veterinary Biologicals Anthrax Vaccines Basic Information List
Table Institute of Veterinary Preventive Medicine Anthrax Vaccines Basic Information List
Table Instituto Rosenbusch S.A. Anthrax Vaccines Basic Information List
Table Institutul Pasteur Anthrax Vaccines Basic Information List
Table Intervac (PVT) Ltd. Anthrax Vaccines Basic Information List
Table Jordan Bio-Industries Center (JOVAC) Anthrax Vaccines Basic Information List
Table KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute) Anthrax Vaccines Basic Information List
Table Laboratorio Prondil S.A. Anthrax Vaccines Basic Information List
Table Laboratorios Laverlam S.A. Anthrax Vaccines Basic Information List
Table Merial Argentina Anthrax Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anthrax Vaccines
Figure Manufacturing Process Analysis of Anthrax Vaccines
Figure Anthrax Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Anthrax Vaccines Major Manufacturers in 2016
Table Major Buyers of Anthrax Vaccines
Table Distributors/Traders List
Figure EMEA Anthrax Vaccines Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Anthrax Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Anthrax Vaccines Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Anthrax Vaccines Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Anthrax Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Anthrax Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Anthrax Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Anthrax Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Anthrax Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Anthrax Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Anthrax Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Anthrax Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Anthrax Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Anthrax Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Anthrax Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Anthrax Vaccines Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Anthrax Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Anthrax Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Anthrax Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Anthrax Vaccines Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Anthrax Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Anthrax Vaccines Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Anthrax Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources